We identified IL16 and IRF4 to be broadly downregulated in tumor-infiltrating DCs, CXCR4 to be broadly upregulated, and IL18 and IL22RA2 increases to be associated with cDC2s (Fig. 5f, Supplemental Fig. 7c). The gene discussed is IL16; the disease is neoplasm.